Hi-Tech Sues FDA To Get Generic Cosopt Exclusivity
Hi-Tech Pharmacal Co. Inc. is asking a judge to force federal regulators to bar other generic-drug makers from the market for generic Cosopt until after the company has had 180 days...To view the full article, register now.
Already a subscriber? Click here to view full article